Travere Therapeutics (TVTX) Shareholder's Equity Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200.79% |
| Dec 31, 2025 | 94.37% |
| Sep 30, 2025 | 341.56% |
| Jun 30, 2025 | 116.19% |
| Mar 31, 2025 | -55.69% |
| Dec 31, 2024 | -70.58% |
| Sep 30, 2024 | -110.89% |
| Jun 30, 2024 | -87.00% |
| Mar 31, 2024 | -60.84% |
| Dec 31, 2023 | 368.62% |
| Sep 30, 2023 | 177.89% |
| Jun 30, 2023 | -25.67% |
| Mar 31, 2023 | -9.13% |
| Dec 31, 2022 | -85.82% |
| Sep 30, 2022 | -67.25% |
| Jun 30, 2022 | -52.84% |
| Mar 31, 2022 | -42.61% |
| Dec 31, 2021 | 43.04% |
| Sep 30, 2021 | 1.98% |
| Jun 30, 2021 | 4.29% |
| Mar 31, 2021 | 60.66% |
| Dec 31, 2020 | -4.51% |
| Sep 30, 2020 | 22.55% |
| Jun 30, 2020 | 15.00% |
| Mar 31, 2020 | -20.99% |
| Dec 31, 2019 | -30.50% |
| Sep 30, 2019 | -22.91% |
| Jun 30, 2019 | -3.78% |
| Mar 31, 2019 | -4.60% |
| Dec 31, 2018 | 8.57% |
| Sep 30, 2018 | 4.78% |
| Jun 30, 2018 | -2.65% |
| Mar 31, 2018 | -0.49% |
| Dec 31, 2017 | -4.75% |
| Sep 30, 2017 | -1.00% |
| Jun 30, 2017 | -5.90% |
| Mar 31, 2017 | -5.73% |
| Dec 31, 2016 | 2.60% |
| Sep 30, 2016 | 5.70% |
| Jun 30, 2016 | 108.50% |
| Mar 31, 2016 | 89.38% |
| Dec 31, 2015 | 905.27% |
| Sep 30, 2015 | 2,956.46% |
| Dec 31, 2014 | -89.41% |
| Sep 30, 2014 | -6.37% |
| Nov 30, 2012 | -4.74% |
| Aug 31, 2012 | -4.54% |
| Feb 29, 2012 | -4.69% |